 |
| CapitalStars Investment Adviser |
Market Live: Nifty likely to open flat.
The Nifty50 is expected to open flat on Wednesday tracking Asian markets which are trading lower as fresh worries about a global recession led investors to dump risky assets, with US President Donald Trump showing no signs of backing down in his trade war with China. Wall Street rally ends as financial shares slide: Financial shares led US stocks lower on Tuesday to end a three-day rally as investors awaited comments from Federal Reserve Chair Jerome Powell at the end of the week, reported Reuters. On August 20, the BSE Sensex shed 74.48 points at 37,328 while the Nifty50 was down 36.90 points to 11,017. Trends on SGX Nifty indicate a flat opening for the broader index in India, with a 0.10 percent loss or 11 points. Nifty futures were trading around 11,017.50-level on the Singaporean Exchange.
Global Market
Asian Markets: Asian markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.39% while the Hang Seng is down 0.02%. The Shanghai Composite is not trading.
US Markets: North and South American markets finished mixed as of the most recent closing prices. The IPC gained 0.36%, while the S&P 500 led the Bovespa lower. They fell 0.79% and 0.25% respectively.
European Markets: European markets finished lower today with shares in London leading the region. The FTSE 100 is down 0.90% while Germany's DAX is off 0.55% and France's CAC 40 is lower by 0.50%.
Major Headlines of the day:
Rupee stands at 71.45 per dollar.
Alembic Pharma says USFDA inspection at Vadodara facility successful, no Form 483 issued There were no 483s issued by USFDA at the end of the inspection, the company said.
Karnataka Govt withdraws approval to extend mining lease period of NMDC In this regard, the company has filed Revision Application against the State Government of Karnataka's above said order with Ministry of Mines, Government of India and the hearing is fixed on 21.08.2019.
Abraxis Biosciences files plea against Sun Pharma Advanced Research alleging infringement of patent SPARC believes that this lawsuit is without merit and will vigorously defend against these allegations.
Trend in FII flows:- The FIIs were Net Value of Rs 373.23 segment while the DIIs were Net Value of 296.41 the provisional figures.
CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY -
Visit our Link : https://bit.ly/2u2GUhK
Visit My Website : https://bit.ly/1h8KZUM
CAPITALSTARS CALL US : 9977499927
0 comments:
Post a Comment